ConductScience.org, home

Paper28871

Effects of aging and liver disease on disposition of lorazepam.

Kraus JW and 5 others. Clin Pharmacol Ther, 1978. Cited by 244 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effects of aging and liver disease on disposition of lorazepam. Papers, record 28871. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28871

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of aging and liver disease on disposition of lorazepam.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
244
iCite
Relative citation ratio, by iCite
14.5
iCite
Revised in PubMed
2019-05-09
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kraus JWJ W
2Desmond PVP V
3Marshall JPJ P
4Johnson RFR F
5Schenker SS
6Wilkinson GRG R

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AgingMajor topic
Anti-Anxiety AgentsMajor topic
Liver DiseasesMajor topic
LorazepamMajor topic
Acute Disease
Adult
Female
Hepatitis, Viral, Human
Humans
Kinetics
Liver Cirrhosis, Alcoholic
Male
Middle Aged

Source PubMed

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 244 citations.

PMIDTitleJournalYearIn PapersSource
37,328,712The Activity of Members of the UDP-Glucuronosyltransferase Subfamilies UGT1A and UGT2B is Impaired in Patients with Liver Cirrhosis.Clin Pharmacokinet2023https://conductscience.org/library/papers/37328712PubMed
37,039,129Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology.J Psychopharmacol2023https://conductscience.org/library/papers/37039129PubMed
28,286,440Medical Care of the Patient With Compensated Cirrhosis.Gastroenterol Hepatol (N Y)2006https://conductscience.org/library/papers/28286440PubMed
27,606,309Sedation in Critically Ill Children with Respiratory Failure.Front Pediatr2016https://conductscience.org/library/papers/27606309PubMed
24,122,696Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment.Clin Pharmacokinet2014https://conductscience.org/library/papers/24122696PubMed
22,933,873Drug interactions: a primer for the gastroenterologist.Gastroenterol Hepatol (N Y)2012https://conductscience.org/library/papers/22933873PubMed
22,050,870Pharmacokinetics of intravenous lorazepam in pediatric patients with and without status epilepticus.J Pediatr2012https://conductscience.org/library/papers/22050870PubMed
21,671,987Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects.Br J Clin Pharmacol2011https://conductscience.org/library/papers/21671987PubMed
19,530,743Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.Drug Saf2009https://conductscience.org/library/papers/19530743PubMed
18,762,933Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.Eur J Clin Pharmacol2008https://conductscience.org/library/papers/18762933PubMed
18,399,712Free drug metabolic clearance in elderly people.Clin Pharmacokinet2008https://conductscience.org/library/papers/18399712PubMed
15,089,805Drug metabolism and ageing.Br J Clin Pharmacol2004https://conductscience.org/library/papers/15089805PubMed
15,086,275Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.Clin Pharmacokinet2004https://conductscience.org/library/papers/15086275PubMed
14,748,812Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.Br J Clin Pharmacol2004https://conductscience.org/library/papers/14748812PubMed
14,678,335Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.Br J Clin Pharmacol2004https://conductscience.org/library/papers/14678335PubMed
10,451,781Pharmacokinetics of opioids in liver disease.Clin Pharmacokinet1999https://conductscience.org/library/papers/10451781PubMed
10,427,466Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes.Clin Pharmacokinet1999https://conductscience.org/library/papers/10427466PubMed
10,408,740Managing alcohol withdrawal in the elderly.Drugs Aging1999https://conductscience.org/library/papers/10408740PubMed
9,784,934Pharmacokinetic alterations after severe head injury. Clinical relevance.Clin Pharmacokinet1998https://conductscience.org/library/papers/9784934PubMed
9,435,992Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients.Clin Pharmacokinet1997https://conductscience.org/library/papers/9435992PubMed

See all 58 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28871

GET https://conductscience.org/api/papers/v1/28871/cited_by?page=2